American Century Focused Intl Gr Inv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
American Century Focused International Growth Fund Investor Class AFCNX
- NAV / 1-Day Return 18.56 / −1.95 %
- Total Assets 198.4M
-
Adj. Expense Ratio
1.100%
- Expense Ratio 1.100%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.02%
- Turnover 90%
USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:11 AM GMT+0
Morningstar’s Analysis AFCNX
Will AFCNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 6.51 | 14M | Technology |
AstraZeneca PLC | 3.68 | 8M | Healthcare |
State Street Bank & Trust Co 3 Repo - 01apr26 | 3.59 | 8M | Cash and Equivalents |
Iberdrola SA | 3.29 | 7M | Utilities |
Societe Generale SA | 2.96 | 6M | Financial Services |
ASML Holding NV | 2.83 | 6M | Technology |
Siemens Energy AG ADR - Sponsored | 2.75 | 6M | Industrials |
BAE Systems PLC | 2.69 | 6M | Industrials |
Novonesis (Novozymes) B Class B | 2.66 | 6M | Basic Materials |
Samsung Electronics Co Ltd | 2.60 | 5M | Technology |